Teva to sell Allergan's UK & Ireland generics business for $770m | Pharmafile
Breakthrough Cancer Research - We are thrilled to announce Teva Pharmaceuticals Ireland (Teva) continued support for cancer research in Ireland through a research grant to our team at our research centre, Cork